A very important finding from the experiments is that if current clinical practice favors the continuation of the PSA test as an initial indicator of prostate cancer, then combining PSA predictor with a subset of flow cytometry predictors can increase the accuracy of the initial PSA test. Here, KLK3 is linked to prostate cancer.